Back to search

Article

HIV-1 co-receptor usage and variable loop contact impacts V3 loop bnAb susceptibility

2019-03-05

Abstract excerpt

<h4>ABSTRACT</h4> In clinical trials, HIV-1 broadly neutralizing antibodies (bnAbs) effectively lower plasma viremia and delay virus reemergence after antiretroviral treatment is stopped among infected individuals that have undetectable virus levels. Presence of less neutralization susceptible strains prior to treatment, however, decreases the efficacy of these antibody-based treatments. The HIV-1 envelope glycop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48df8394-3319-54b5-ad2e-896515491136
DOI
10.1101/568469
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HIV-1 co-receptor usage and variable loop contact impacts V3 loop bnAb susceptibilityDOI 10.1101/568469
Select a neighboring publication to make it the new centre.